Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
Jung Hyun YoonKyunghwa HanEunjung LeeJandee LeeEun-Kyung KimHee Jung MoonVivian Youngjean ParkKee Hyun NamJin Young KwakPublished in: PloS one (2020)
Radiomics features extracted from US has limited value as a non-invasive biomarker for predicting the presence of BRAFV600E mutation status of PTC regardless of size.